The cell lines transfected with shRNA targeting NLE1, A549-shNLE1 and NCI-H1299-shNLE1, were developed to unveil the effects of NLE1 knockdown on the malignant behaviors of NSCLC cells (Figure S1). The gene discussed is NLE1; the disease is non-small cell lung carcinoma.